These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

128 related articles for article (PubMed ID: 9673018)

  • 41. A novel screening method based on menadione mediated rapid reduction of tetrazolium salt for testing of anti-mycobacterial agents.
    Singh U; Akhtar S; Mishra A; Sarkar D
    J Microbiol Methods; 2011 Feb; 84(2):202-7. PubMed ID: 21129420
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Inhibition of growth and nucleic acid synthesis in zinc-deficient Mycobacterium smegmatis.
    Harris AB
    J Gen Microbiol; 1969 Apr; 56(1):27-33. PubMed ID: 4239593
    [No Abstract]   [Full Text] [Related]  

  • 43. Anti-dormant mycobacterial activity and target analysis of nybomycin produced by a marine-derived Streptomyces sp.
    Arai M; Kamiya K; Pruksakorn P; Sumii Y; Kotoku N; Joubert JP; Moodley P; Han C; Shin D; Kobayashi M
    Bioorg Med Chem; 2015 Jul; 23(13):3534-41. PubMed ID: 25934225
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Maladaptive DNA repair is the ultimate contributor to the death of trimethoprim-treated cells under aerobic and anaerobic conditions.
    Giroux X; Su WL; Bredeche MF; Matic I
    Proc Natl Acad Sci U S A; 2017 Oct; 114(43):11512-11517. PubMed ID: 29073080
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Inhibition of mycobacterial growth by plumbagin derivatives.
    Mathew R; Kruthiventi AK; Prasad JV; Kumar SP; Srinu G; Chatterji D
    Chem Biol Drug Des; 2010 Jul; 76(1):34-42. PubMed ID: 20456370
    [TBL] [Abstract][Full Text] [Related]  

  • 46. [Mode of action of ethambutol. Effect of ethambutol on the incorporations of several isotopic compounds into lipids, nucleic acids and protein by Mycobacterium smegmatis].
    Tsukamura M; Mizuno S
    Kekkaku; 1967 Nov; 42(11):437-42. PubMed ID: 5586755
    [No Abstract]   [Full Text] [Related]  

  • 47. Metabolic profiling of dormant Mycolicibacterium smegmatis cells' reactivation reveals a gradual assembly of metabolic processes.
    Nikitushkin VD; Trenkamp S; Demina GR; Shleeva MO; Kaprelyants AS
    Metabolomics; 2020 Feb; 16(2):24. PubMed ID: 32025943
    [TBL] [Abstract][Full Text] [Related]  

  • 48. ["In vitro" susceptibility of some aerobic and anaerobic bacteria to three 5-nitro-imidazole derivatives: metronidazole, ornidazole and tinidazole (author's transl)].
    Dublanchet A; Durieux R
    Ann Microbiol (Paris); 1980; 131(1):45-59. PubMed ID: 7362180
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Mutation of tlyA confers capreomycin resistance in Mycobacterium tuberculosis.
    Maus CE; Plikaytis BB; Shinnick TM
    Antimicrob Agents Chemother; 2005 Feb; 49(2):571-7. PubMed ID: 15673735
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Mode of action of deoxypheganomycin D on Mycobacterium smegmatis ATCC 607.
    Suzukake-Tsuchiya K; Hori M; Shimada N; Hamada M
    J Antibiot (Tokyo); 1988 May; 41(5):675-83. PubMed ID: 3384753
    [TBL] [Abstract][Full Text] [Related]  

  • 51. [In vitro determination of the sensitivity of mycobacteria to fluoroquinolones].
    Dailloux M; Petitpain N; Henry C; Weber M
    Pathol Biol (Paris); 1989 May; 37(5):346-9. PubMed ID: 2780092
    [TBL] [Abstract][Full Text] [Related]  

  • 52. [Recent progress in mycobacteriology].
    Okada M; Kobayashi K
    Kekkaku; 2007 Oct; 82(10):783-99. PubMed ID: 18018602
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Study of the in vitro susceptibility of M. tuberculosis to ofloxacin in Spain. Spanish Study Group of M. tuberculosis resistance.
    Casal M; Ruiz P; Herreras A
    Int J Tuberc Lung Dis; 2000 Jun; 4(6):588-91. PubMed ID: 10864193
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Low-oxygen-recovery assay for high-throughput screening of compounds against nonreplicating Mycobacterium tuberculosis.
    Cho SH; Warit S; Wan B; Hwang CH; Pauli GF; Franzblau SG
    Antimicrob Agents Chemother; 2007 Apr; 51(4):1380-5. PubMed ID: 17210775
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Qualitative and quantitative proteomic analysis of Vitamin C induced changes in Mycobacterium smegmatis.
    Mishra A; Sarkar D
    Front Microbiol; 2015; 6():451. PubMed ID: 26042100
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Protein synthesis is shutdown in dormant Mycobacterium tuberculosis and is reversed by oxygen or heat shock.
    Hu YM; Butcher PD; Sole K; Mitchison DA; Coates AR
    FEMS Microbiol Lett; 1998 Jan; 158(1):139-45. PubMed ID: 9453166
    [TBL] [Abstract][Full Text] [Related]  

  • 57. An investigation of interactions between metronidazole ("Flagl") and other antibacterial agents.
    Salem AR; Jackson DD; McFadzean JA
    J Antimicrob Chemother; 1975 Dec; 1(4):387-91. PubMed ID: 1107295
    [No Abstract]   [Full Text] [Related]  

  • 58. Dormancy of Mycobacterium tuberculosis and latency of disease.
    Wayne LG
    Eur J Clin Microbiol Infect Dis; 1994 Nov; 13(11):908-14. PubMed ID: 7698116
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Response of Mycobacterium smegmatis to acid stress.
    O'Brien LM; Gordon SV; Roberts IS; Andrew PW
    FEMS Microbiol Lett; 1996 May; 139(1):11-7. PubMed ID: 8647369
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Targeting dormant phenotype acquired mycobacteria using natural products by exploring its important targets:
    Sharma S; Chikhale R; Shinde N; Khan AM; Gupta VK
    Front Cell Infect Microbiol; 2023; 13():1111997. PubMed ID: 37033483
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.